April 11, 2018 / 7:05 AM / 9 days ago

BRIEF-Kineret approved by EU for treatment of Still's disease

April 11 (Reuters) - Swedish Orphan Biovitrum AB (publ) :

* KINERET® (ANAKINRA) APPROVED IN THE EU FOR THE TREATMENT OF STILL’S DISEASE

* SAYS EU HAS APPROVED AN EXTENSION OF THE INDICATION FOR KINERET (ANAKINRA) TO INCLUDE THE TREATMENT OF STILL’S DISEASE, INCLUDING SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) AND ADULT-ONSET STILL’S DISEASE (AOSD), IN ALL 28 EUROPEAN UNION (EU) MEMBER STATES. Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below